Treeline Biosciences is a biotechnology company founded by Josh Bilenker, M.D. and Jeff Engelman M.D., Ph.D. The name was curated to connote the concept of the outer limits of scientific possibilities, the places where conditions are a challenge but the metaphorical trees and forests still thrive and grow.
Treeline Biosciences is focused on oncology molecular targets that are currently validated but have to date been difficult to successfully drug. Treeline Biosciences believes their unique approach may further be applied to other areas of therapeutics as well.